来自MSN25 天
Medtronic's deep brain stimulation system for Parkinson's disease wins FDA nod
Medtronic (NYSE:MDT) has won FDA approval for a deep brain stimulation system for Parkinson’s disease.The approval is for BrainSense Adaptive deep brain stimulation (DBS)and BrainSense Electrode ...
Yahoo Finance26 天
Medtronic gains FDA OK for self-adjusting DBS system for Parkinson’s
Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous ...
News Medical19 天
Medtronic receives FDA approval for BrainSense Adaptive DBS technology
Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology, introducing aDBS for people living with Parkinson's. This feature personalizes ...
Nasdaq25 天
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation ...
Now Medtronic has enhanced its Percept™ DBS neurostimulators with exclusive BrainSense™ Adaptive technology†, introducing aDBS for people living with Parkinson's. This feature personalizes ...
Investing25 天
Medtronic's new adaptive DBS system gains FDA approval
Deep brain stimulation (DBS) has been instrumental in managing Parkinson's symptoms for over three decades. Medtronic's Percept™ DBS neurostimulators now incorporate BrainSense™ Adaptive ...
Benzinga.com25 天
FDA Approves Medtronic's Adaptive Deep Brain Stimulation System For Parkinson's Patients
Medtronic's BrainSense aDBS personalizes Parkinson's therapy in real-time, minimizing manual adjustments for better symptom control. BrainSense Electrode Identifier speeds up initial DBS ...
Investing25 天
Medtronic's new adaptive DBS system gains FDA approval
GALWAY, Ireland - Medtronic plc (NYSE:MDT), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $115.42 billion, has announced the FDA approval of its ...